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0022-2836© 2010 Elsevier Ltd.Open acceThe first committed step in the classical biosynthetic route to menaquinone
(vitamin K2) is a Stetter-like conjugate addition of α-ketoglutarate with
isochorismate. This reaction is catalyzed by the thiamine diphosphate and
metal-ion-dependent 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexa-
diene-1-carboxylate synthase (MenD). The medium-resolution (2.35 Å)
crystal structure of Bacillus subtilis MenD with cofactor and Mn2+ has been
determined. Based on structure–sequence comparisons and modeling, a
two-stage mechanism that is primarily driven by the chemical properties of
the cofactor is proposed. Hypotheses for the molecular determinants of
substrate recognition were formulated. Five basic residues (Arg32, Arg106,
Arg409, Arg428, and Lys299) are postulated to interact with carboxylate
and hydroxyl groups to align substrates for catalysis in combination with a
cluster of non-polar residues (Ile489, Phe490, and Leu493) on one side of the
active site. The powerful combination of site-directed mutagenesis, where
each of the eight residues is replaced by alanine, and steady-state kinetic
measurements has been exploited to address these hypotheses. Arg409
plays a significant role in binding both substrates while Arg428 contributes
mainly to binding of α-ketoglutarate. Arg32 and in particular Arg106 are
critical for recognition of isochorismate. Mutagenesis of Phe490 and Ile489
has the most profound influence on catalytic efficiency, indicating that these
two residues are important for binding of isochorismate and for stabilizing
the cofactor position. These data allow for a detailed description of the
structure–reactivity relationship that governs MenD function and refine-
ment of the model for the catalytic intermediate that supports the Stetter-
like conjugate addition.© 2010 Elsevier Ltd.Open access under CC BY license. Keywords: crystal structure; enzyme mechanism; menaquinone biosynth-
esis; thiamine diphosphate cofactorEdited by G. SchulzIntroduction
Menaquinone, or vitamin K2, is a lipid-soluble
molecule with distinct functions according to theress:
me A; PDB, Protein
anomalous
enolpyruvyl-6-
late; SeMet,
iphosphate; PEG,
ss under CC BY license. type of organism in which it is found. Its chemical
properties are exploited in the electron transport
(respiratory) chain in Gram-positive aerobes and
facultative Gram-negative bacteria under anaerobic
conditions.1 Gram-negative bacteria use menaqui-
none only under anaerobic conditions, using ubi-
quinone under aerobic conditions.2 In mammals,
which acquire menaquinone from intestinal micro-
flora and diet, it is an important cofactor for
glutamate γ-carboxylation, an essential posttransla-
tional modification of proteins involved in blood
coagulation, bone metabolism, and vascular
biology.3
Menaquinone biosynthesis has been most studied
in Escherichia coli.1 The starting point is chorismate,
254 Structure–Function of B. subtilis MenDthe branch point intermediate of the Shikimate
pathway.4 Chorismate is first isomerized to isochor-
ismate and then converted, in three stages, to o-
succinyl-1-benzoate. Two further enzyme-catalyzed
reactions, involving ATP and coenzyme A (CoA),
lead to a CoA-naphthalene derivative before a
recently identified thioesterase removes the CoA
moiety to release 1,4-dihydroxy-2-napthanoate.5
Prenylation, followed by methylation, then pro-
duces menaquinone. An alternative and distinct
route to menaquinone exists in a small subset of
bacteria such as Helicobacter pylori.6 The starting
point remains chorismate but the intermediates
include an inosine derivative, futalosine.
Our interest centers on 2-succinyl-5-enolpyruvyl-6-
hydroxy-3-cyclohexadiene-1-carboxylate (SEPHCHC)
synthase (EC 2.2.1.9) called MenD, the enzyme that
catalyzes the first committed step of the classical
menaquinone biosynthetic route (Fig. 1). Initially, the
thiamine diphosphate (ThDP)-dependent MenD was
misassigned as a bifunctional 2-succinyl-6-hydroxy-
2,4-cyclohexadiene-1-carboxylate synthase7 catalyzing
decarboxylation of α-ketoglutarate and then ligation
of a second substrate, isochorismate, to produce
SEPHCHC. Cleavage of the pyruvate moiety then
produced 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-
carboxylate. Subsequent studies revealed that MenD
is a monofunctional SEPHCHC synthase and the
only enzyme known to catalyze addition of a ThDP
intermediate to the β-carbon of a second substrate,
in a Stetter-like reaction, which is a 1,4-conjugate
addition of an aldehyde to a β-unsaturated
compound.8 A complication in previous studies
was the spontaneous release of pyruvate from
SEPHCHC giving the misleading perception that a
bifunctional enzyme was present.9,10 Jiang et al.
showed that the enzyme encoded by the menH gene
is actually responsible for the catalytic cleavage of
pyruvate from SEPHCHC (Fig. 1).9
The majority of genes that code for enzymes
involved in menaquinone biosynthesis, including
menD, have been shown by gene knockout to be
essential in Bacillus subtilis.11 Such methods also
indicate essentiality of MenD in HaemophilusFig. 1. The reactions catalyzed by MenD ainfluenzae12 and Mycobacterium tuberculosis.13 Since
these are two important pathogens, then the
understanding of MenD function and activity has
potential to inform on early-stage drug discovery
research.14
The structure of MenD from E. coli in complex with
its cofactor ThDP,15 the apo structure of EcMenD,16
and a complex with oxoglutaric acid in the absence of
cofactor17 have been determined. In the latter
structure, the ligand binds at the site normally
occupied by the ThDP diphosphate and so does not
provide any information about substrate binding.We
now report the medium-resolution crystal structure
of the B. subtilis enzyme (BsMenD), solved by
targeting the anomalous dispersion signal from a
selenomethionine (SeMet) derivative. A comparison
of structures and sequences of MenD orthologues
guided molecular modeling, which has allowed us to
generate hypotheses concerning the functional roles
for eight residues in the active site. A detailed kinetic
analysis of the wild-type enzyme and eight point
mutations serve to address questions concerning
recognition and processing of substrate and have
allowed us to elucidate the structure–reactivity
relationship that governs MenD activity.Results and Discussion
General comments
BsMenD crystallizes in an orthorhombic system,
space group P212121, with four polypeptide chains,
labeled A to D in the asymmetric unit. The mass of
protein in the tetramer is about 256.4 kDa. The
structure was solved by use of single-wavelength
anomalous diffraction (SAD) methods and refined
to 2.35 Å resolution. The crystallographic statistics
and model geometry (Table 1) indicate that the
analysis has produced an acceptable medium-
resolution model. Continuous and well-defined
electron density was observed for each polypeptide
chain from Thr2 to Leu580, except for chain C wherend MenH in menaquinone biosynthesis.
Table 1. Crystallographic and model geometry statistics
for BsMenD
SeMet
derivative Native
Resolution range (Å) 50–3.0a 68.8–2.35
Unit cell dimensions:
a, b, c (Å)
100.1, 152.6,
158.1
100.2, 153.0,
158.5
Space group P212121 P212121
Total/unique reflections 633,457/93,394 720,895/101,958
Redundancy/
completeness (%)b
6.8c/99.7 (99.4) 7.1/100 (100)
Wilson B (Å2) 23.5 41.0
〈I/σ(I)〉 16.5 (7.1) 17.3 (4.1)
Rmerge 10.4 (27.5) 10.9 (39.4)
Protein residues
(A/B/C/D)
579/579/577/579
Water molecules/
ThDP/Mn2+
1075/4/4
SO4
2−/ethane-1,2-diol 8/4
Rwork/Rfree/DPI (Å)
d 17.3/22.9/0.23
Average B-factors (Å2)
Overall/side chain/
main chain
Subunit A 31.3/31.8/30.8
Subunit B 35.9/36.3/35.5
Subunit C 35.3/35.7/34.9
Subunit D 30.4/30.8/30.1
Water molecules/
ThDP/Mn2+
34.7/23.0/25.8
SO4
2−SO4
2-/
ethane-1,2-diol
20.2/28.4
r.m.s.d. bond lengths
(Å)/angles (°)
0.009/1.32
Ramachandran plot
analysis (%)e
Favorable/outliers 96.8/0.6
a The limit of the useful anomalous signal.
b Values in parentheses refer to the highest-resolution shell;
3.16–3.0 Å (SeMet), 2.41–2.35 Å (native).
c Friedel pairs treated separately.
d The diffraction-component precision index as defined by
Cruickshank.18
e According to MolProbity.19
255Structure–Function of B. subtilis MenDthe final two residues were not observed. Overlay
of the chains using Secondary-Structure Matching20
gives root-mean-square deviations (r.m.s.d.'s) in
the range 0.22–0.30 Å, indicating that the subunits
are, within the errors associated with a medium-
resolution structure, essentially identical. We therefore
detail only subunit A, unless stated otherwise.
Overall structure
MenD shows the three-domain architecture typi-
cal of ThDP-dependent enzymes (Fig. 2).21 Sequence
and structural analyses place MenD in the pyruvate
oxidase class of these enzymes, where domain I
contains the cofactor pyrimidine-binding motif,
domain III binds the diphosphate, and the central
domain has variable, often ill-defined, function. In
BsMenD, domain I spans approximately the first 190
residues. An ordered linker region leads into
domain II, which consists of residues 205–345. A
smaller linker then leads into domain III, whichstarts at approximately residue 355 and continues to
the C terminus (Fig. 2). Each domain consists of a
parallel β-sheet sandwiched between several α-
helices; in BsMenD, the central domain has five
strands and there are six in domains I and III.
Quaternary structure
Oligomerization is essential for the function of
ThDP-dependent enzymes, with each active site
formed from two subunits.21 Most of these enzymes
function as either dimers or tetramers. Size-exclusion
chromatography indicated that BsMenD consists of a
mixture of dimer and tetramer in solution, with the
dimer being much more abundant. The crystal
structure of BsMenD consists of a dimer-of-dimers
(Fig. 3); a similar result was found for EcMenD,
which is predominantly dimeric in solution15 and
then forms a dimer-of-dimers when crystallized.15–17
Analysis using the Protein Interfaces, Surfaces and
Assemblies server22 suggests that the dimer-of-
dimers is the most stable oligomeric form, burying
approximately 23% (5310 Å2) of the surface area of
each subunit (23,100 Å2). The principal interface,
between subunits A and B (and C and D), buries
about 14% of the surface area of each subunit. The A:
B interface covers an area of about 3130 Å2, and the
C:D interface covers approximately 3160 Å2.
Around 30 hydrogen bonds in addition to the salt
bridges formed between Arg53 and Asp55 with
their counterparts in the second dimer form themost
important interactions in this interface (data not
shown). Fewer hydrogen bonds link the dimer-of-
dimers arrangement where the pairs of subunits
involved are A:D and B:C. This interface is formed
primarily by residues located in the linker between
domains I and II. A short three-amino-acid stretch of
β-strand is present at the start of domain II, which
forms an extension of the parallel β-sheet of domain
II across the interface. In addition, another three-
residue stretch (205–207) forms a two-stranded
antiparallel β-sheet across the interface. Approxi-
mately 7% of the surface area of a subunit is buried
at this interface; 1610 and 1620 Å2 for the A:D and B:
C interface regions, respectively. The A:C and B:D
interfacial regions occlude about 700 and 710 Å2,
respectively, each representing approximately 2% of
the subunit surface area.
Comparison with EcMenD
The MenD proteins from different organisms
share little sequence identity, typically in the range
20–30%. Such a low level of sequence conservation
despite the same function appears to be a common
feature of enzymes that are dependent on ThDP.15
BsMenD has 28% overall sequence identity to the E.
coli protein. The sequence identity is higher for
domains I and III (32% and 33%, respectively)
compared to the central domain (16%). Neverthe-
less, the structures of the two enzymes are closely
related, with the majority of secondary-structure
elements conserved in each domain (Fig. 4). One
Fig. 3. The BsMenD tetramer.
The tetramer is shown as a van
der Waals surface with subunits
labeled and colored differently.
Subunit A is in the same orientation
as in Fig. 2.
Fig. 2. The secondary and domain structure of BsMenD. A ribbon diagram of the enzyme subunit showing the
elements of secondary structure with atoms of ThDP depicted as spheres according to atom type: C, gray; N, blue; O, red;
S, yellow; P, orange. The N- and C-terminal positions are labeled, as are the elements of secondary structure.
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Fig. 4. The primary and assigned secondary structure of BsMenD and EcMenD. α-Helices are shown as cylinders and β-strands as arrows, colored according to the domain to
which they have been assigned (see Fig. 2). Residues with a black background are strictly conserved.
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Fig. 5. ThDP interactions with BsMenD. Atoms are
colored as follows: C of ThDP, black; C of protein, gray for
subunits A and B; P, orange; N, blue; O, red; S, yellow;
Mn2+, purple. Purple continuous lines represent coordi-
nation of the transition metal ion, and black broken black
lines represent potential hydrogen-bonding interactions.
258 Structure–Function of B. subtilis MenDexception is the final helix in domain I of EcMenD,
which is replaced by a loop andβ7 inBsMenD (Fig. 4).
This region does not appear to have any functional
role.
Subunit A from BsMenD overlays with a subunit
from EcMenD [Protein Data Bank (PDB) code: 2jlc]
with an r.m.s.d. of approximately 2.0 Å (over 503
aligned Cα). The closeness of the structures extends to
the dimer (r.m.s.d. of 2.0 Å over 1006 aligned Cα) and
the tetramer (2.4 Å over 1996 Cα). Individual domains
align more closely; domain I of BsMenD overlays
with an r.m.s.d. of 1.3 Å onto domain I of EcMenD
(173 aligned Cα), domain II with an r.m.s.d. of 1.8 Å
(117 aligned Cα), and domain III with an r.m.s.d. of
1.7 Å (over 196 aligned Cα). The loop containing
residues responsible for binding to the diphosphate
group of ThDP (approximately residues Gly486 to
Pro509) is disordered in EcMenD in the absence of
cofactor16 but ordered in the holo-enzyme.15 The
conformation of this cofactor-binding loop in holo-
BsMenD is similar to that of the corresponding loop
in the holo-Ec structure (data not shown).
The low level of sequence identity between
BsMenD and EcMenD serves to highlight the critical
determinants of structure and function, and we
placed a particular emphasis on conservation when
analyzing potential contributions that residues
make to enzyme activity. In the following text,
unless stated otherwise, we confine our discussion
to residues that are strictly conserved between
BsMenD and EcMenD.
Cofactor binding and the active site
Dimerization is essential for formation of the
cofactor binding and active site, with residues from
domain I of subunit A and domain III from subunit
B forming one site (and vice versa, leading to two
active sites per dimer, Fig. 3). A metal cation,
assigned as Mn2+, is bound and helps to position
the diphosphate group of ThDP and so tether one
part of the cofactor to the protein. This is a
common feature of ThDP binding and similar to
what is observed in EcMenD.15 In BsMenD, the
side chains of Asp457 and Asn484, the main-chain
carbonyl of Gly486, a water molecule, and two
oxygen atoms from the diphosphate group form an
octahedral coordination sphere about the metal ion
(Fig. 5).
Almost all ThDP-dependent enzymes have a
glutamate interacting with N1′ of the pyrimidine;
Glu54 fulfills this role in BsMenD. Mutagenesis of
the corresponding residue, Glu55, in EcMenD
completely abolished enzyme activity.7 The main-
chain amide of Ile433 and carbonyl of Asn431,
which participate in hydrogen-bonding interactions
with N3′ and N4′, respectively, are from the partner
subunit. The side chain of Ile433, a residue strictly
conserved inMenD sequences,15 is placed to interact
with both the pyrimidine and thiazolium rings
helping to hold the cofactor in a V shape, bent at
C7′. All ThDP-dependent enzymes that have been
structurally characterized have a large hydrophobicside chain in exactly this position. The environment
of the cofactor forces N4′ on the pyrimidine ring into
close contact with C2 in the thiazolium ring (3.1 Å,
Fig. 5), activating the cofactor to contribute to
catalysis.
ThDP binding involves contributions from a pair
of subunits. The diphosphate is bound between the
N-terminal section of α14, strands β16 and β17, and
the loop between β17 and α17. The pyrimidine
moiety is positioned near the loop linking β15–α15.
These are all from one subunit. The partner subunit
contributes to binding the pyrimidine with con-
tributions from the C-terminal sections of β1 and β3,
the loop between β3 and α4, together with an
important contribution from Glu54 at the N termi-
nus of α3. The thiazolium group is sandwiched
between Ile433 (on the loop linking β15 with α15)
and Phe490 (α17).
The narrow crevice where substrates bind is
likewise formed by a dimer. One subunit contributes
three α-helical segments (α10, α14, and α17), which
line one side of the cavity. Three non-helical
segments (the β1–α2 turn, the loop between β6
and β7, and the loop following β4) are provided by
the partner subunit. The active site is polar,
primarily basic due to the presence of four arginine
residues (32A, 106A, 409B, and 428B) and a lysine
(299B). A hydrophobic patch is formed by Ile489B,
Phe490B, and Leu493B (Fig. 6). Seven of these eight
amino acids are strictly conserved, and one, Lys299,
is conserved or replaced by arginine in more than
90% of MenD sequences.
Ser405 OG donates a hydrogen bond to one of the
phosphate groups of ThDP yet is placed about 3.1 Å
from the thiazolium S. This alignment of functional
groups may induce a polarization effect on the S
atom and contribute to generation of an ylide.
Fig. 6. A model for the post-decarboxylation covalent adduct formed after ThDP C2 has reacted with α-ketoglutarate
and then isochorismate. A stereoview into the active site with atoms colored as follows: C of ThDP, black; C of protein,
gray; O, red; N, blue; P, orange; Mn2+, purple. The eight key residues discussed in the text are labeled. Two water
molecules are depicted as gray spheres and ethane-1,2-diol is shown as gray sticks, labeled EDO.
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The structure of MenD and our model (Fig. 6) of
the activated intermediate–isochorismate complex
suggested that the actual enzyme mechanism is
driven by the chemical properties of the cofactorFig. 7. A two-stage mechanism for catalysis by BsMenD. An
by the carbanion intermediate. The post-decarboxylation cova
modeled and is shown in Fig. 6.ThDP. A two-stage mechanism that corresponds to
reactions with each of the substrates can be
proposed (Fig. 7).15 The absence of any residue
that can act as a general acid/base indicates that the
cofactor N4′ is a critical component of the mecha-
nism. Such an observation is consistent withasterisk (⁎) marks the isochorismate C2, which is attacked
lent intermediate in stage II is the structure that has been
Table 2. Steady-state kinetic parameters with respect to
α-ketoglutarate
Protein
Km
(μM)
kcat
(min−1)
kcat/Km
(μM−1 min−1)
Relative
kcat/Km
Wild type 22±5 14±2 0.64±0.3 1
R409A 159±18 2.7±0.3 0.16±0.02 0.03
R428A 514±54 3.4±0.2 0.007±0.001 0.01
R32A′ 22±4 4.8±0.4 0.22±0.02 0.3
R106A′ 7.7±2.2 0.6±0.2 0.09±0.03 0.1
K299A 22±4 22±2 1±0.2 1.5
L493A 18±1 10±1 0.5±0.1 0.8
I489A 346±10 5.7±0.2 3.1±0.1 0.01
F490A 274±12 1.1±0.1 0.0039±0.0002 0.006
Residues marked with ′ are located in the second subunit forming
the active site.
Table 3. Steady-state kinetic parameters with respect to
isochorismate
Protein
Km
(μM)
kcat
(min−1)
kcat/Km
(μM−1 min−1)
Relative
kcat/Km
Wild type 1.1±0.2 19±1 19±3 1
R409A 8.5±1.2 1.4±0.1 0.16±0.02 0.009
R428A 1.1±0.5 2.8±0.8 2.8±0.8 0.15
R32A′ 49±7 11±1 0.22±0.01 0.01
R106A′ 41±4 0.7±0.2 0.018±0.01 0.00095
K299A 8.4±1.2 25±2 3.0±0.3 0.16
L493A 39±1 19±1 0.49±0.03 0.03
I489A 27±1 5.7±0.2 0.21±0.01 0.01
F490 29±3 1.7±0.1 0.058±0.01 0.003
Residues marked with ′ are located in the second subunit forming
the active site.
260 Structure–Function of B. subtilis MenDstructural and mechanistic studies of another ThDP-
dependent enzyme, N2-(2-carboxyethyl)arginine
synthase.23
Our model for activity predicts that five polar
residues interact with carboxylates and hydroxyl
group of substrates to align reagents for catalysis and
that non-polar components of isochorismate interact
with the hydrophobic patch. The structural studies,
sequence comparisons, molecular modeling, and
mechanistic considerations lead us to conclude that
the environment provided by MenD for the cofactor
and the chemical properties of ThDP provide the
functionality for catalysis. A first approximation of
how substrates bind can then be used to address the
molecular recognition of these substrates.
Mutagenesis and kinetic studies
Attempts to soak ligands such as α-ketoglutarate
and salicylic acid into the crystals of BsMenD and
thus derive structural data directly relevant to
substrate recognition resulted in the loss of diffrac-
tion. Co-crystallization experiments were also car-
ried out but either no crystals were observed or,
where analyzed, there was no electron density that
could be attributed to these ligands (data not
shown). A model of the post-decarboxylation
covalent adduct formed after reaction of ThDP
with first α-ketoglutarate then isochorismate (Figs.
6 and 7) was constructed, guided by the principle
that important features relevant to substrate recog-
nition and catalysis should be conserved between
BsMenD and EcMenD. We also noted that the
positions of two water molecules and ethane-1,2-
diol in the active sites serve to identify potential
ligand interacting sites and provide a hint of where
functional groups of isochorismate might be placed
(Fig. 6).
Modeling of substrate binding, sequence, and
structure comparisons identified eight residues that
are potentially important with respect to substrate
recognition. The first stage of the reaction involves
the formation of a covalent adduct between the
cofactor and α-ketoglutarate; the formation of such
species is well established in ThDP-dependent
enzymes24 and the adduct structure has been
captured crystallographically.25 The driving force
for this stage largely comes from the geometry of the
cofactor in the binding site, which brings N4′ of the
pyrimidine ring and C2 of the thiazolium ring into
close proximity. N4′ abstracts the acidic proton from
C2, generating a carbanion ylide, which can then
attack the first substrate, α-ketoglutarate, to form
the first covalent intermediate (Fig. 7). Arg409 and
Arg428 (Fig. 5) are well placed to interact with the α-
ketoglutaric acid part of this adduct. Mutation of
these residues to alanine had a significant effect on
the binding of α-ketoglutarate and the rate of
reaction (Table 2). The Arg409Ala mutation resulted
in a 7-fold increase in Km and 5-fold decrease in kcat.
The Arg428Ala mutation gave an increase in Km of
more than 20-fold and a 4-fold decrease in kcat. These
mutations resulted in comparable kcat/Km values,which are significantly decreased, compared to the
wild-type enzyme. Assay of these two mutants with
respect to isochorismate indicates that Arg409 has a
greater influence on the second substrate binding
since the Km is increased 8-fold with no change to Km
of the Arg428Ala mutant (Table 3). Although
catalytic efficiency is compromised in both cases,
ascribed to poorer binding of α-ketoglutarate in the
first stage of the reaction, the Arg409Ala mutant is
affected to a much larger degree with a reduction in
kcat/Km by 2 orders of magnitude. These data
suggest then that Arg409 is important for binding
of both substrates whereas Arg428 primarily con-
tributes to the binding of α-ketoglutarate. This is
consistent with the crystal structure since the side
chain of Arg409 is about 1 Å closer to the thiazolium
group than Arg428, at the base of the active site cleft
directed towards the cavity where the second
substrate binds.
Arg32 and Arg106 are in close proximity on one
side of the active-site entrance; Lys299 is about 8 Å
distant on the other side of the cleft. Arg106 is the
closest to the thiazolium group at a distance of about
9 Å. The model of the covalent or activated
intermediate suggests that this triumvirate of basic
residues is likely to have a small influence, if any, on
α-ketoglutarate binding. The kinetic data (Table 2)
indeed suggest that this is the case. There is
effectively no change to Km with respect to α-
261Structure–Function of B. subtilis MenDketoglutarate for the Arg32Ala and Lys299Ala
mutants, and Km is reduced by a factor of 3 for the
Arg106Ala protein. With respect to isochorismate
(Table 3), the Lys299Ala mutant displays an increase
in Km of about 8-fold but with a comparable kcat
value, whereas the mutations to the two arginine
residues increase Km between 40- and 50-fold and
reduce kcat significantly. The reduction in catalytic
efficiency is most pronounced for the Arg106
mutation. These data are consistent with Arg106
performing an important role in recognition and
binding of the second substrate.
Three hydrophobic residues, Ile489, Phe490, and
Leu493, cluster on one side of the active site (Fig. 6).
Of these, Leu493 is most distant, about 9.5 Å from
the thiazolium. The kinetic data indicate a minor
perturbation of BsMenD activity when Leu493 is
mutated to alanine and this is mainly due to an
increase in Km for isochorismate. Leu493 does not
therefore appear to make a particularly significant
or direct contribution to reactivity. The changes to
kinetic properties may be due to perturbation of the
hydrophobic cluster since the other two residues
appear more important. Mutation of Ile489 and
Phe490 increases the Km for α-ketoglutarate 16-fold
and 12-fold, respectively. The Km for isochorismate
is increased by 24- and 25-fold, respectively, and
there is a concomitant reduction in catalytic effi-
ciency. Ile489 is adjacent to the site where α-
ketoglutarate reacts with the thiazolium group,
3.8 Å distant from the sulfur atom. Phe490 partici-
pates in van der Waals interactions with the
thiazolium and Ile489. These two residues appear
therefore to help bind ThDP. Ile489 is likely to
interact with the aliphatic part of the intermediate
formed after α-ketoglutarate has reacted with ThDP
and, together with Phe490, to interact with the
hydrophobic component of the isochorismate ring,
C3 and C4 (Fig. 6).
In the second stage of the reaction, the carbanion
adduct attacks isochorismate C2 (Fig. 7). Two
further arginine residues (Arg32 and Arg106) and
a lysine (Lys299) line one side of the putative
isochorismate-binding region. A hydrophobic
patch consisting of Ile489, Phe490, and Leu493
(Fig. 6) lines the opposite side of the active site.
Kinetic characterization of Ala mutants of each of
these residues is summarized in Tables 2 and 3, with
respect to both substrates. Mutation has little effect
on the binding of ThDP (data not shown).
Lys299, the only highlighted residue located in the
central domain, appears to have little influence on
the reaction. Mutation of any of the arginine
residues has a similar effect on the binding of
isochorismate; however, alteration to Arg106 has a
greater impact upon the rate of reaction. This
residue is located at the start of the long loop
linking β4 with β5; in addition to its putative role in
the reaction, Arg106 is well placed to form a
hydrogen bond with the main-chain carbonyl of
Pro116, helping to orient this loop, which forms part
of the binding pocket. Removal of this interaction
could destabilize the loop. Of the hydrophobicresidues, mutation of Phe490 has the most deleteri-
ous effect, with respect to both substrates, indicating
particular importance in defining the overall shape
and size of the binding pocket.
Concluding remarks
This combination of single crystal diffraction
methods with site-directed mutagenesis and kinetic
analyses has allowed us to elucidate the structure–
reactivity relationship that governs MenD activity.
The enzyme provides the environment to bind the
cofactor in a specific manner such that the mecha-
nism is driven by the chemical properties of ThDP.
There is no requirement for any amino acid to
contribute directly to the mechanism by abstraction
or provision of a proton. Rather, the residues in the
active site are important for the binding and
orientation of substrates allowing MenD to accom-
plish catalysis. The mutagenesis data are consistent
with such a conclusion since they indicate that the
most profound effect on catalytic efficiency is
derived from alteration of non-polar residues
implicated in substrate recognition.Materials and Methods
Reagents, preparation of recombinant expression
systems, and protein purification
Chemicals and materials were sourced from Sigma-
Aldrich and VWR International except where stated
otherwise. The menD gene was amplified by PCR from
B. subtilis genomic DNA (ATCC strain 23857, LGC
Standards Office, UK) with 5′-CTCGAGATGACAGT-
GAACCCAATTAC-3′ and 5′-GGATCCTTACAGTTCC-
CATTGTTTTTTC-3′ as the forward and reverse primers,
respectively (Thermo Scientific). These oligonucleotides
include 5′ XhoI and 3′ BamHI restriction sites, respective-
ly, indicated in boldface. The PCR product was ligated
into TOPO-BLUNT-II (Invitrogen) and then sub-cloned
into a modified pET15b vector (Novagen), which pro-
duces a histidine-tagged protein with a tobacco etch virus
protease site. The hexa-His tag, tobacco etch virus
cleavage site, and additional residues from the choice of
cloning sites added a total of 24 extra amino acids at the
protein N terminus. The native and SeMet-labeled
proteins were obtained using E. coli strains BL21(DE3)
and the methionine auxotroph B834 (DE3) (Stratagene),
respectively. Cells were grown in 1 L of Luria–Bertani
media supplemented with 50 μg mL−1 of carbenicillin for
production of native protein, while for the SeMet protein,
bacteria were cultured in minimal media (Molecular
Dimensions) supplemented with SeMet following an
established protocol.26 Gene expression was induced at
20 °C using 0.5 mM isopropyl-β-D-thiogalactopyranoside,
and growth continued for 16 h at room temperature.
The same purification protocol was used for both native
and SeMet BsMenD. Cells were harvested by centrifuga-
tion for 25 min at 40,000g at 4 °C, re-suspended in lysis
buffer (50 mM Tris–HCl, pH 7.5, 250 mM NaCl, and
20 mM imidazole) containing DNase I (0.1 mg) and a
single tablet of a cocktail of ethylenediaminetetraacetic
acid-free protease inhibitors (Roche), and lysed using a
French press at 1000 psi. Insoluble debris was separated
262 Structure–Function of B. subtilis MenDby centrifugation at 39,000g for 25 min at 4 °C, and the
soluble fraction was loaded onto a 5-mL HisTrap HP
column (GE Healthcare) pre-charged with Ni2+. A linear
concentration gradient was applied to the column and
BsMenD eluted at a concentration of 250 mM imidazole.
Fractions were analyzed using SDS-PAGE, and those
containing BsMenD were pooled. The protein, still
carrying the affinity tag, was further purified using a
Superdex 200 26/60 size-exclusion column (GE Health-
care) equilibrated with 50 mM Tris–HCl and 250 mM
NaCl, pH 7.5. This column had previously been calibrated
with molecular mass standards, blue dextran (N2000 kDa),
thyroglobulin (669 kDa), ferritin (440 kDa), aldolase
(158 kDa), conalbumin (75 kDa), ovalbumin (43 kDa),
carbonic anhydrase (29.5 kDa), ribonuclease A (13.7 kDa),
and aprotinin (6.5 kDa) (GE Healthcare; data not shown).
Selected fractions were pooled and dialyzed into 20 mM
Tris–HCl and 50 mM NaCl, pH 7.5, and concentrated
using Amicon Ultra devices (Millipore) to 8 mg mL−1 for
the native protein and 4 mg mL−1 for the SeMet sample.
The protein concentration was determined spectrophoto-
metrically using a theoretical extinction coefficient of
52,745 M−1 cm−1 at 280 nm calculated using ProtParam.27
The full incorporation of SeMet and high level of sample
purity for both samples was verified by matrix-assisted
laser desorption/ionization time-of-flight mass spectrom-
etry and SDS-PAGE (data not shown). The native protein
expressed at levels in excess of 150 mg L−1 of culture;
yields of the SeMet protein were lower, typically about
60 mg L−1, due to the lower bacterial cell mass obtained in
minimal media.
The native protein typically eluted from the gel-
filtration column in two peaks: a major peak with a
mass of approximately 150 kDa and a minor peak of with
a mass of approximately 290 kDa. The theoretical mass of
a BsMenD subunit is approximately 64.1 kDa, and
therefore, the peaks correspond to a dimer and tetramer,
respectively. Approximately 10% of the total protein was
observed in the minor peak, which was discarded, and the
major peak was used subsequently.
Crystal growth, structure determination, and refinement
Crystallization and data collection
Sitting and hanging drop vapor diffusion methods were
used to screen and optimize crystallization conditions,
respectively, based on commercially available screening
sets. The BsMenD:ThDP:Mn2+ complex crystallized with
the N-terminal hexa-His tag intact whereas the apo-
enzyme did not crystallize at all. Holo-enzyme was
prepared by incubation with 2 mM MnCl2 and 0.5 mM
ThDP, and crystals were obtained using a reservoir
(500 μL) comprising 35% polyethylene glycol (PEG)
1.5K, 0.1 M Tris, pH 8, and 0.25 M (NH4)2SO4, for the
native protein and 24% PEG 3K, 0.1 M Tris, pH 8, and
0.2 M Li2SO4 for SeMet BsMenD. In both cases, the best
crystals were obtained from drops consisting of 1 μL
protein and 2 μL of reservoir. Crystals appeared as
rectangular prisms, consistently with a notch at one end.
The maximum dimensions of native crystals were
0.3 mm×0.1 mm×0.1 mm, and the SeMet derivative
crystals were smaller at 0.2 mm×0.1 mm×0.1 mm.
Crystals were flash cooled in liquid nitrogen, mounted
on a goniostat, and maintained at −173 °C in a flow of
cooled nitrogen, and diffraction properties were charac-
terized with a Rigaku Micromax 007 rotating anode R-
AXIS IV++ image plate system. The best samples were
stored for use at the European Synchrotron RadiationFacility (Grenoble, France). Crystals of both proteins,
particularly the SeMet crystals, were radiation sensitive.
Native data were collected on beam line ID23-1, and SAD
data were measured on beam line BM14, both with ADSC
Q315 CCD detectors. The SAD data were collected at the
Se K-absorption edge, determined using X-ray Absorption
Near Edge Structure spectroscopy to provide the f″
maximum at a wavelength of 0.97864 Å. Data were
integrated using XDS28 and scaled with XSCALE
(SeMet)28 or SCALA (native),29 and statistics are presented
in Table 1.Structure solution and refinement
Attempts to solve the BsMenD structure by molecular
replacement using the EcMenD mode (PDB code: 2jlc)
gave ambiguous results; the sequence identity shared
between the two is 28%. Since the asymmetric unit was
predicted to contain 68 methionine residues, based on four
subunits per asymmetric unit, it was judged likely that a
SeMet-SAD experiment would provide useful phase
information.
Analysis of the SAD data using XPREP30 indicated
that the anomalous dispersion signal/noise ratio re-
duced to a value of 1.0 at 3 Å resolution and these data
were input to the program SOLVE.31 Initial phases were
obtained by SAD phasing based on the positions of 30
selenium atoms. The initial figure of merit was 0.25 with
a Z-score of 62.3. Density modification using
RESOLVE32 with an estimated solvent content of 55%
improved the figure of merit to 0.75. Automated map
interpretation with RESOLVE produced a partial model
consisting of approximately 1300 residues split over 52
polypeptide chains. This model was extended using
Coot33 with the benefit of the EcMenD structure as a
guide. The major secondary-structure elements of a
single subunit were completed, and the resulting
structure was used as a molecular replacement model
for the native data, using Phaser.34 The four subunits
present in the asymmetric unit were all located with Z-
scores above 12, indicating correct solutions. Further
manual rebuilding, the placement of the cofactor ThDP,
Mn2+ and SO4
2− ions and waters using Coot, and
incorporation of dual rotamer side chains interspersed
with refinement using REFMAC5.35 A strong electron
density feature was observed in each active site and this
was successfully modeled and refined as ethane-1,2-diol,
a precursor of and potential contaminant in PEGs.36
Strict non-crystallographic symmetry restraints were
applied during the initial stages of refinement; these
were relaxed and then removed as the refinement
progressed. Model geometry statistics are presented in
Table 1. Subunits A and D are involved in more contacts
with symmetry-related molecules, leading to significantly
lower B-factors for these chains (Table 1). Figures were
prepared with Chemdraw (Adept Scientific), PyMOL,37
and ALINE.38Mutagenesis and kinetic studies
The QuikChange Site-Directed Mutagenesis Kit (Strata-
gene) was used to introduce eight point mutations into
BsMenD. The primers used to generate the mutants are
listed in Supplemental Table 1. Expression and purifica-
tion of the mutants followed the procedures described
above for the native protein. Preparation and purification
of isochorismate followed previous protocols.39 Protein
activity was measured by monitoring the decrease in
263Structure–Function of B. subtilis MenDabsorption at 278 nm due to the consumption of
isochorismate.8 All kinetic assays were carried out in
50 mM Tris–HCl, pH 7.8, with 20 mM NaCl and 5 mM
MgSO4 at 23 °C. Circular dichroism measurements
indicated that in each case, the mutated protein was still
correctly folded (data not shown).
PDB accession numbers
Coordinates and structure factors have been deposited
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